Cargando…

Efficacy of a fixed dose combination of irbesartan and atorvastatin (Rovelito(®)) in Korean adults with hypertension and hypercholesterolemia

PURPOSE: Coexistence of hypertension (HTN) and hypercholesterolemia is a major synergistic and modifiable risk factor for cardiovascular disease (CVD). Thus, a fixed-dose combination (FDC) of anti-HTN drugs and statins may be useful for treating CVD. This study evaluated the efficacy of an FDC of ir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ihm, Sang-Hyun, Shin, Jinho, Park, Chang-Gyu, Kim, Cheol-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387596/ https://www.ncbi.nlm.nih.gov/pubmed/30858694 http://dx.doi.org/10.2147/DDDT.S191973

Ejemplares similares

Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
por: Bramlage, Peter
Publicado: (2009)

Physicochemical Characterization of a Co-Amorphous Atorvastatin-Irbesartan System with a Potential Application in Fixed-Dose Combination Therapy
por: Skotnicki, Marcin, et al.
Publicado: (2021)

Efficacy and Safety of a Fixed Combination of Irbesartan/Hydrochlorothiazide in Chinese Patients with Moderate to Severe Hypertension
por: Huang, Qi-Fang, et al.
Publicado: (2013)

Efficacy of Irbesartan on Left Ventricular Mass and Arterial Stiffness in Hypertensive Patients
por: Park, Chang Gyu, et al.
Publicado: (2006)

Efficacy and tolerability of two different formulations of atorvastatin in Korean patients with hypercholesterolemia: a multicenter, prospective, randomized clinical trial
por: Lee, Ju-Hee, et al.
Publicado: (2017)

Therapeutic effect of irbesartan combined with atorvastatin calcium in the treatment of rats with coronary heart disease
por: Li, Tao, et al.
Publicado: (2018)

Efficacy and Safety of High-Dose Atorvastatin in Moderate-to-High Cardiovascular Risk Postmenopausal Korean Women with Dyslipidemia
por: Moon, Jaecheol, et al.
Publicado: (2020)

Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets
por: Ghim, Jong-Lyul, et al.
Publicado: (2019)

Long-term use and tolerability of irbesartan for control of hypertension
por: Forni, Valentina, et al.
Publicado: (2011)

Is Time an Important Problem in Management of Hypertension and Hypercholesterolemia by Using an Amlodipine-Atorvastatin Single Pill Combination?
por: Zeng, Rui, et al.
Publicado: (2016)

The effect of alcohol dose on the development of hypertension in Asian and Western men: systematic review and meta-analysis
por: Jung, Mi-Hyang, et al.
Publicado: (2020)

2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension
por: Lee, Hae-Young, et al.
Publicado: (2019)

2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension
por: Kim, Hyeon Chang, et al.
Publicado: (2019)

Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)
por: Clearfield, Michael B, et al.
Publicado: (2006)

Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan
por: Gialama, Fotini, et al.
Publicado: (2013)

2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations
por: Kim, Kwang-il, et al.
Publicado: (2019)

Development of Atorvastatin Calcium Biloaded Capsules for Oral Administration of Hypercholesterolemia
por: Senthilvel, Chitra Karthikeyini, et al.
Publicado: (2022)

An Eight-Week Trial Investigating the Efficacy and Tolerability of Atorvastatin for Children and Adolescents With Heterozygous Familial Hypercholesterolemia
por: Gandelman, Kuan, et al.
Publicado: (2011)

Home blood pressure monitoring: a position statement from the Korean Society of Hypertension Home Blood Pressure Forum
por: Ihm, Sang-Hyun, et al.
Publicado: (2022)

Comparative Study of Low Doses of Rosuvastatin and Atorvastatin on Lipid and Glycemic Control in Patients with Metabolic Syndrome and Hypercholesterolemia
por: Park, Jong-Seon, et al.
Publicado: (2010)

Comparison between effects of different doses of Melissa officinalis and atorvastatin on the activity of liver enzymes in hypercholesterolemia rats
por: Zarei, Ali, et al.
Publicado: (2014)

Resistant hypertension: consensus document from the Korean society of hypertension
por: Park, Sungha, et al.
Publicado: (2023)

Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study
por: Han, Seung Hwan, et al.
Publicado: (2018)

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes
por: Nakamura, Makiko, et al.
Publicado: (2014)

Clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy
por: Liu, Jie, et al.
Publicado: (2022)

Clinical features and predictors of masked uncontrolled hypertension from the Korean Ambulatory Blood Pressure Monitoring Registry
por: Kim, Hyun-Jin, et al.
Publicado: (2021)

Retracted: Development of Atorvastatin Calcium Biloaded Capsules for Oral Administration of Hypercholesterolemia
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

A Fast and Validated Reversed-Phase HPLC Method for Simultaneous Determination of Simvastatin, Atorvastatin, Telmisartan and Irbesartan in Bulk Drugs and Tablet Formulations
por: Alhazmi, Hassan A., et al.
Publicado: (2017)

Irbesartan in experimental diabetic nephropathy
por: Mahajan, Rajiv, et al.
Publicado: (2010)

Higher Blood Pressure Variability in White Coat Hypertension; from the Korean Ambulatory Blood Pressure Monitoring Registry
por: Kang, In Sook, et al.
Publicado: (2016)

Pharmacokinetic non-interaction analysis in a fixed-dose formulation in combination of atorvastatin and ezetimibe
por: Patiño-Rodríguez, Omar, et al.
Publicado: (2014)

Determinants of persistence in hypertensive patients treated with irbesartan: results of a postmarketing survey
por: Burnier, Michel, et al.
Publicado: (2005)

Action of irbesartan on blood pressure and glucose/lipid metabolism, in hemodialysis patients with hypertension
por: Onishi, Akira, et al.
Publicado: (2013)

Clinical and life style factors related to the nighttime blood pressure, nighttime dipping and their phenotypes in Korean hypertensive patients
por: Kim, Byung Sik, et al.
Publicado: (2023)

The impact of hypotestosteronemia on cardiometabolic effects of atorvastatin in men with hypercholesterolemia: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2021)

Efficacy of alternate-day versus everyday dosing of atorvastatin
por: Pramanik, Sushobhan, et al.
Publicado: (2012)

Statement on chronotherapy for the treatment of hypertension: consensus document from the Korean society of hypertension
por: Park, Sungha, et al.
Publicado: (2023)

Clinical and epidemiological implications of the data on the Korean clinical hypertension cohort
por: Shin, Jinho
Publicado: (2023)

The antihypertensive effect of irbesartan in spontaneously hypertensive rats is associated with improvement of the leptin–adiponectin imbalance
por: Weng, Junting, et al.
Publicado: (2021)

Effects of Irbesartan and Amlodipine Besylate Tablets on the Intestinal Microflora of Rats With Hypertensive Renal Damage
por: Yu, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pb18tu9b6im2lqk355fda63t3h